Randomized Crossover Comparison of Injection Site Pain with 40 mg/0.4 or 0.8 mL Formulations of Adalimumab in Patients with Rheumatoid Arthritis
Crossref DOI link: https://doi.org/10.1007/s40744-016-0041-3
Published Online: 2016-08-18
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nash, Peter
Vanhoof, Johan
Hall, Stephen
Arulmani, Udayasankar
Tarzynski-Potempa, Rita
Unnebrink, Kristina
Payne, Andrew N.
Cividino, Alfred
Text and Data Mining valid from 2016-08-18
Version of Record valid from 2016-08-18
Article History
Received: 9 June 2016
First Online: 18 August 2016